Thunder Biotech is the operator of a biotechnology company intended to treat cancer. The company employs technology to treat cancer by empowering patients' immune systems to combat and eradicate the disease by modifying a patient's own immune cells (called macrophages) to have receptors that target cancer cells. Thunder Biotech was established in 2016 by Tod Schulthess in Alpine, Utah.

PhytoHealth is a drug development company that works to develop new drugs in compliance with international standards and regulations. It manufactures an injectable drug for the treatment of cancer and drugs that reduce the risk of cardiovascular diseases. The company was founded in 1998. It is a member of Maywufa Biopharma Group and the only drug development company listed on the Taiwan stock market.

Nippon Zoki Pharmaceutical Co. Ltd. is a private company headquartered in Chuo-ku, Japan, that manufactures pharmaceutical products.

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Faron Pharmaceuticals Oy operates as a clinical stage biopharmaceutical company. It develops novel treatments for medical conditions with significant unmet needs caused by dysfunction of immune system. The firm currently has a pipeline based on the receptors involved in regulation of immune response in oncology, organ damage and bone marrow regeneration. Its Bexmarilimab, a novel anti-Clever-1 humanized antibody, is its investigative precision immunotherapy with the potential to provide permanent immune stimulation for difficult-to-treat cancers through targeting myeloid function. The company was founded by Juho Markku Jalkanen, Sirpa Tuulikki Jalkanen, Matti Esa Manner, Juha Peltola, Marko Salmi, Katriina Peltola and Maija-Leena Hollmen in 2003 and is headquartered in Turku, Finland.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

CellAxia is a biotechnology startup that creates medications for cell treatment. Drug discovery bio-venture aiming at the practical application of advanced research such as cell therapy. It serves clients operating in the healthcare sector.

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

Beijing Hengfeng Mingcheng Biotechnology Co., Ltd., established on 2016-05-04, Business scope includes stem cells,Technical development of biological products,technical consulting,Technology Promotion,Technical Services;Production of Class I Medical Devices;Agent import and export,Technology Import and Export,Import and export;Sales instrumentation,chemical reagent,Chemical Products(Free of Hazardous Chemicals),cosmetic,medical instrumentsI,IIkind,hygiene products,daily necessities;Conference Services;Undertake the exhibition;Health Advisory,health management(Except for medical treatment activities subject to approval);design,make,acting,Place an ad;retail medicine.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Retail Drugs and Items Subject to Legal Approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Cornell provides education about the earth and atmospheric sciences. They offer summer and winter sessions. Their students contact them through phone and email services.

Shanghai Nanotechnology and Application National Engineering Research Center Co., Ltd., established on 2004-08-20, Business scope includes research and development of nanotechnology and related technologies,Production and sales of nano-related products,Technology development in the nanosphere,technology transfer,technical consulting,Technical Services,Investment in projects and products,account Serive. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Riptide Bioscience is developing medicines with lifesaving potential, using strategies common to almost all organisms. Like most plants and animals, the human body uses small proteins called "Host Defense Peptides" (HDPs) to defend against microbial invasion, particularly for wounds or burns which would otherwise quickly be colonized by hostile bacteria.